A randomised community based study to assess the safety, efficacy of dihydroartemisinin-piperaquine (artekin) for the treatment of uncomplicated falciparum malaria

Not Applicable

Completed

• Conditions: Malaria; Infections and Infestations

• Registration Number: ISRCTN50708498
• Lead Sponsor: niversity of Oxford (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-10-14
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 0

Inclusion Criteria

1. Adults or children
2. Symptomatic of malaria infection, i.e. history of fever or presence of fever more than 37.5 °C
3. Microscopic confirmation of asexual stages of P. falciparum or mixed infection (5/500 white blood cells)

Exclusion Criteria

1. Pregnancy or lactation
2. P.falciparum asexual stage parasitaemia greater than or equal to 4% red blood cells (175,000 /µl)
3. Signs or symptoms of severe malaria

Study & Design

• Study Type: Interventional
• Study Design: Not specified